This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Types

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • papillary adenocarcinoma : 80% } termed "differentiated" thyroid cancer
  • follicular adenocarcinoma : 10% }
  • medullary adenocarcinoma : 5%
  • anaplastic carcinoma : 3%
  • thyroid lymphoma : about 1%

Reference:

  1. NICE (November 2004). Improving outcomes in head and neck cancers - The Manual

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.